Diabetes & Ramadan (DAR) Alliance And Sanofi Introduce New Integrated Digital Hub To Help Patients With Diabetes Across The World
The Diabetes and Ramadan (DAR) Alliance, in collaboration with Sanofi, has announced the launch of an integrated digital hub, which will help patients around the world manage their diabetes during the Ramadan period and beyond. It will also allow physicians to access up-to-date medical information that are relevant to the needs of patients from across the region.
“Nowadays, it’s easy to find high quality medical information – they are readily available on the internet and on our mobile devices. However, there remains a significant unaddressed needs specific to the one quarter of the world’s population: the Islamic population,” said Dr. Mohamed Hassanein, Chairman of the DAR Alliance. “Launching the new platform, we aim to address these needs for the first time ever and continue to become valuable partners for doctors treating patients, to people with diabetes, and the public in general globally.”
The DAR Alliance integrated digital platform contains various informational tools, including the DAR alliance website (daralliance.org), which serves as a hub housing links from where a category of users can access relevant content.
Healthcare professionals can make full use of the dedicated educational platform, the DAR Academy (daralliancehcp.org) to visit educational webcasts, download useful resources, and access a plethora of information. Under the name “DAR SaFa” (Diabetes and Ramadhan Safe Fasting), the general public will have access to the “Diabetes Nutrition Plan,” complemented by the all new “Know What You eat” section, where they can assess diabetes-tailored meals. In addition, they can also view educational videos on a diverse range of topics – from medical tips to religious information for the month of Ramadan.
Each sections of the hub has dedicated mobile applications for both iOS and Android devices. Currently in English, all content will soon be available in other languages, including Arabic and French.
“At Sanofi, we always strive to reinforce our leadership and long heritage in diabetes. Our commitment goes beyond delivering advanced therapies that address high unmet medical needs; we collaborate with partners such as the Diabetes and Ramadan (DAR) Alliance to provide innovative solutions with the ultimate goal of improving the lives of people. We are delighted that this pioneer initiative, born in the UAE, will be able to help millions of people in the region and the world,” said Jean-Paul Scheuer, Country Chair & General Manager for Sanofi Gulf Countries.